Gloucester Pharmaceuticals

Gloucester Pharmaceuticals

Gloucester Pharmaceuticals acquires clinical-stage oncology drug candidates and advances them through approvals and commercialization. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€582m (Public information from Dec 2009)
Cambridge Massachusetts (HQ)
  • Edit
DateInvestorsAmountRound
N/A

$15.0m

Series B
N/A

$10.0m

Convertible
N/A

$2.0m

Convertible
N/A

$5.3m

Convertible
N/A

$2.0m

Convertible
N/A

$4.0m

Convertible
N/A

$2.0m

Convertible
N/A

$41.8m

Series C
N/A

$5.3m

Series C
N/A

$3.0m

Convertible
N/A

$3.2m

Debt
N/A

$1.5m

Debt
N/A

$500k

Debt

$29.0m

Series D

$640m

Valuation: $640m

Acquisition
Total Funding€109m

Recent News about Gloucester Pharmaceuticals

Edit
More about Gloucester Pharmaceuticalsinfo icon
Edit

Gloucester Pharmacy is a healthcare provider that goes beyond the traditional pharmacy model by offering personalized care to its clients. Located in the Middle Peninsula, the pharmacy serves a diverse range of customers, including individuals seeking prescription refills and those in need of over-the-counter remedies. The business operates in the healthcare market, focusing on both prescription and non-prescription products. Its business model revolves around providing high-quality, personalized healthcare services, which include filling prescriptions and offering a complete line of non-prescription remedies. The pharmacy generates revenue through the sale of these products and services, aiming to meet the unique healthcare needs of its community.

Keywords: personalized care, prescription refills, non-prescription remedies, healthcare, Middle Peninsula, pharmacy, customer-focused, high-quality service, healthcare provider, community-focused.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.